The growing resistance of microorganisms to antibiotics has been considered as a global public health problem. Therefore, the search for novel antimicrobial drugs, chemically unrelated to the presently used antibiotics, is urgently needed. Our group has recently characterized a new family of antimicrobial peptides – phylloseptins – isolated from the skin secretion of the South American amphibian Phyllomedusa hypochondrialis, which showed a strong antimicrobial effect against Gram-positive and Gram-negative bacteria. We now investigate the in vivo toxicity of synthetic phylloseptin-1 (PS-1) toward bone marrow, liver, spleen, kidney and lung after endovenous administration to Swiss mice of a bolus dose of 4 mg/kg. Genotoxicity was evaluated by quantifying erythrocyte micronuclei. PS-1-treated mice showed no alteration in the histology of liver, spleen, kidney and lung, as well as of blood biochemistry, as compared to normal controls. Cytotoxicity tests, evaluated either by blood cytometry or bone marrow polychromatophilic erythrocyte index, revealed no deleterious effect of PS-1. Moreover, the peptide showed no toxicity towards bone marrow erythrocytes. We concluded that, in a concentration ten times over that providing antimicrobial effect, synthetic PS-1 showed no in vivo toxicity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ambroggio E. E., Separovic F., Bowie J. H., Fidelio G. D., Bagatolli L. A. (2005) Biophys. J. 89:1874–1881
Andrès E., Dimarcq J. L. (2004) Rev. Med. Interne 25:629–635
Apponyi M. A., Pukala T. L., Brinkworth C. S., Maselli V. M., Bowie J. H., Tyler M. J., Booker G. W., Wallace J. C., Carver J. A., Separovic F., Doyle J., Llewellyn L. E. (2004) Peptides 25:1035–1054
Black M. T., Hodgson J. (2005) Adv. Drug Deliv. Rev. 57:1528–1538
Blondelle S. E., Houghten R. A. (1991) Biochemistry 30:4671–4678
Brand G. D., Leite J. R. S. A., Silva L. P., Albuquerque S., Prates M. V., Azevedo R. B., Carregaro V., Silva J. S., Sá V. C. L., Brandão R. A., Bloch Jr. C. (2002) J. Biol. Chem. 277:49332–49340
Bolliger A. P. (2004) Vet. Clin. Pathol. 33:58–67
Brillard J. P., Mcdaniel G. R. (1985) Poult. Sci. 64:155–158
Chen T., Farragher S., Bjourson A. J., Orr D. F., Rao P., Shaw C. (2003) Biochem. J. 371:125–130
Chen T., Xue Y., Zhou M., Shaw C. (2005) Peptides 26:377–383
Clark, G.: 1980, Stained Procedures, 4th ed., Williams & Wilkins, Baltimore, London
Colvin, M. and Chabner, B. A.: 1990, in: Chabner, B. A., Collins, J. M. (eds.), Cancer Chemotherapy: Principles and Practices, J.B. Lippencott, Philadelphia, California, pp. 276–313
Cunha Filho G. A., Schwartz C. A., Resck I. S., Murta M. M., Lemos S. S., Castro M. S., Kyaw C., Pires Jr. O. R., Leite J. R. S. A., Bloch Jr. C., Schwartz E. F. (2005) Toxicon 45:777–782
Evans H. J. (1997) Mutat. Res. 392:5–10
Glantz S. A. (1992). Primer of Biostatistics. McGraw Hill, New York
Goluszko P., Nowicki B. (2005) Infect. Immun. 73:7791–7796
Hancock R. E. W., Diamond G. (2000) Trends Microbiol. 8:402–410
Krugliak M., Feder R., Vadim Y., Zolotarev L. G., Dagan A., Ginsburg H., Mor A. (2000) Antimicrob. Agents Chemother. 44:2442–2451
Leite J. R. S. A., Silva L. P., Rodrigues M. I. S., Prates M. V., Brand G. D., Lacava B. M., Azevedo R. B., Bocca A. L., Albuquerquee S., Bloch Jr. C. (2005) Peptides 26:565–573
Merrifield R. B. J. (1963) Chem. Soc. 85:2149-2156
Matsuzaki K. (1999) Biochim. Biophys. Acta 1462:1–10
Mor A., Nguyen V. H., Delfour A., Migliore S. D., Nicolas P. (1991) Biochemistry 30:8824–8830
Moura, R. A. A. (ed.): 1982, in Técnicas de Laboratório, Ed. Atheneu, Rio de Janeiro, RJ, pp. 77–119
Ownby C. L., Powell J. R., Jiang M. S., Fletcher J. E. (1997) Toxicon 35:67–80
Peschel A. (2002) Trends Microbiol. 10:179–186
Rabelo-Gay, M. N.: 1991, in: Rabelo-Gay, M. N., Rodrigues, M. A. L. R., Monteleone-Neto, R. (eds.), Mutagênese, teratogênese e carcinogênese: métodos e critérios de avaliação, Sociedade Brasileira de Genética, Ribeirão Preto, São Paulo, pp. 83–90
Schmid W. (1975) Mutat. Res. 31:9–15
Silva L. P. (2004) Lett. Drug Design Discov. 3:230–236
Sitaram N., Nagaraj R. (1999) Biochim. Biophys. Acta 1462:29–54
Shiri J., Navon-Venezia S., Feder R., Gaidukov L., Carmeli Y., Mor A. (2002) Antimicrob. Agents Chemother. 46:689–694
Stark M., Liu L. P., Deber C. M. (2002) Antimicrob. Agents Chemother. 46:3585–3590
Steiner H., Hultmark D., Engstrom A., Bennich H., Boman H. G. (1981) Nature 292:246–248
Tomasinsig L., Skerlavaj B., Papo N., Giabbai B., Shai Y., Zanetti M. (2006) J. Biol. Chem. 281:383–391
Vanhoye D., Bruston F., Nicolas P., Amiche M. (2003) Eur. J. Biochem. 270:2068–2081
World Health Organization: 2000, Drug resistance threatens to reverse medical progress, Press Release WHO/41.12
World Health Organization: 2001, Good Laboratory Practice (GLP) UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (document no. TDR/PRD/GLP/01.1B)
Acknowledgments
This work was supported by the Brazilian Conselho Nacional de Desenvolvimento Científico e Tecnológico. We are grateful to Centro Universitário de Brasília (UniCEUB) for the donation of the mice used in this research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kückelhaus, S., Leite, J.R.S.A., Neves, M.P. et al. Toxicity Evaluation to Mice of Phylloseptin-1, an Antimicrobial Peptide from the Skin Secretion of Phyllomedusa hypochondrialis (Amphibia). Int J Pept Res Ther 13, 423–429 (2007). https://doi.org/10.1007/s10989-006-9060-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10989-006-9060-1